Mitoxantrone for MS linked to colorectal cancer risk

[News]

Treatment with mitoxantrone for multiple sclerosis carries only a mildly increased risk of malignancy overall, but the risk of colorectal cancer and leukaemia is heightened, researchers have found.

More... (http://www.news-medical.net/news/20160524/Mitoxantrone-for-MS-linked-to-colorectal-cancer-risk.aspx)